Vanguard Personalized Indexing Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,946	Closed	-$616K	–	1675
2023 Q4	$616K	Buy	1,946 +584	+43%	+$114K	0.02%	889
2023 Q3	$230K	Buy	1,362 +421	+45%	+$79.2K	0.01%	1234
2023 Q2	$204K	Buy	+941	New	+$202K	0.01%	1327

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Vanguard Personalized Indexing Management's KRTX Position: Q1 2024 in Review

Vanguard Personalized Indexing Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,946 shares — an estimated $616K sold.

Vanguard Personalized Indexing Management first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $616K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Vanguard Personalized Indexing Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 1,946 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $616K.
Vanguard Personalized Indexing Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
Vanguard Personalized Indexing Management's Karuna Therapeutics, Inc. Common Stock position peaked at $616K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2024, filed 9 May 2024.